Trifarotene, sold under the brand name Aklief, is a topical retinoid medication used for the treatment of acne vulgaris on the face and trunk. It is a fourth-generation retinoid, specifically a selective retinoic acid receptor-γ (RAR-γ) agonist, which makes it highly effective in targeting the primary receptor involved in skin health. This selectivity allows trifarotene to treat acne effectively, with potentially fewer side effects compared to earlier retinoid generations. Trifarotene is formulated as a cream and applied directly to the skin.
![3''-(tert-butyl)-4'-(2-oxoethoxy)-4''-(pyrrolidin-1-yl)-[1,1':3',1''-terphenyl]-4-carboxylic acid C29H31NO4](https://veeprho.com/wp-content/uploads/2023/04/3-tert-butyl-4-2-oxoethoxy-4-pyrrolidin-1-yl-1-1-3-1-terphenyl-4-carboxylic-acid.png "3''-(tert-butyl)-4'-(2-oxoethoxy)-4''-(pyrrolidin-1-yl)-[1,1':3',1''-terphenyl]-4-carboxylic acid C29H31NO4")
Parent: Trifarotene
![4-(10-(tert-butyl)-7-hydroxy-9-(pyrrolidin-1-yl)-6,7-dihydrodibenzo[b,d]oxepin-2-yl)benzoic acid C29H31NO4](https://veeprho.com/wp-content/uploads/2026/08/4-10-tert-butyl-7-hydroxy-9-pyrrolidin-1-yl-67-dihydrodibenzobdoxepin-2-ylbenzoic-acid-C29H31NO4-NA-VE0011571-3389.png "4-(10-(tert-butyl)-7-hydroxy-9-(pyrrolidin-1-yl)-6,7-dihydrodibenzo[b,d]oxepin-2-yl)benzoic acid C29H31NO4")
Parent: Trifarotene
During the production and storage of trifarotene, impurities can develop that must be carefully monitored to ensure the medication’s safety and efficacy. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) provide strict guidelines for permissible impurity levels in pharmaceutical products to ensure patient safety.
When using AKLIEF (trifarotene), avoid prolonged exposure to sunlight or UV lamps, as the medication can increase skin sensitivity to UV rays. Also, avoid products containing alcohol, astringents, or other irritating ingredients, which can worsen dryness and irritation.
Avoid using other topical acne treatments containing retinoids or strong exfoliants while using trifarotene, as they can lead to increased irritation. Additionally, products with benzoyl peroxide and harsh cleansers should be avoided. It’s best to consult a healthcare provider before combining trifarotene with other skincare products.
Trifarotene should be applied once daily in the evening. Nighttime application minimizes potential irritation from sun exposure and allows the medication to work during the skin’s repair cycle. Make sure to cleanse and dry your skin before application.
Yes, it is common for AKLIEF (trifarotene) to cause an initial purging phase, where acne may appear to worsen before it improves. This happens as the medication increases skin cell turnover, bringing impurities to the surface.
